Navigation Links
Herceptin Not A ‘Wonder’ Drug, Says The Lanct

After receiving glowing tributes for its miraculous properties, Herceptin, the breast cancer wonder drug came down to earth as the most respected British medical journal questioned its effectiveness//.

"The available evidence is insufficient to make reliable judgments. It is profoundly misleading to suggest, even rhetorically, that the published data may be indicative of a cure for breast cancer," the editors of The Lancet wrote in an article that was released online on Wednesday. This castigation comes just three week's after the New England Journal of Medicine called the drug 'revolutionary.' Health care providers on this side of the Atlantic are not amused by the wide publicity that has been given to the drug. It is since sparked a wide demand for Herceptin with some patients even taking the legal recourse to avail a prescription for the same. "Study results are preliminary, inconsistent and raise extremely serious concerns about safety," The Lancet's chief editor, Dr. Richard Horton, said. He added that he was angry that the NEJM had published this without adequately assessing the drug's impact.

Basically Herceptin is designed for women whose breast cancer has undergone a genetic mutation and responds poorly to traditional means of treatment. In other words, only advanced cancers can benefit by its use. The Lancet decided to take action after the British health secretary, Patricia Hewitt, publicly demanded the National Health Service provide the drug to a woman who had sued for the same. "The last thing we should want is to have a politician campaigning on behalf of a drug," Horton commented. "It's a crazy way to make what should be a scientific decision."

Meanwhile, Roche, the Swiss makers of the drug said that they had read The Lancet article, but did not agree with it. The journal said that Herceptin caused heart failure in the women who used it. Katja Prowald, a spokeswoman for the company said that they would be releasing a further analysis on Thursday.

"The debate about the availability of Herceptin to women with early breast cancer demands cooler heads than have so far prevailed, in politics, in public, and even in medical journals," The Lancet editorial concluded.
'"/>




Related medicine news :

1. Nurse wins her case over use of Herceptin for her Breast cancer
2. Drug Herceptin To Be Recommended To All Breast Cancer Patients
3. Herceptin Is A Possible Cure For Breast Cancer
4. £6000 to be refunded to Mrs. Leese for Herceptin treatmen
5. Wangaratta Community fundraising for Herceptin drug
6. Herceptin for Early Stage Breast cancer
7. Treatment of Breast Cancer with Herceptin for Nine Weeks
8. Herceptin is the cure for early stages of breast cancer?
9. 10-year-old Pleads, Herceptin For My Mum, Please
10. Norfolk PCTs To Offer Herceptin
11. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... therapy products, announced today the introduction of the newly designed, innovative shoulder wrap. ... and better cold therapy coverage for the injured arm and shoulder to promote ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... i2i Systems, ... of the highest preliminary data vendors in the latest KLAS report, Population Health Management ... has led the developing market for population health management (PHM). The latest KLAS ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory ... federallabs.org . The site houses a wealth of federal resources that businesses can ... process called technology transfer (T2). As a network of over 300 federal laboratories, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... The Valentine’s Season is famous for gift giving ... significant others that they are loved. This year, for more than 5.6 million Americans ... - just won't be enough to remind them of the lives they’ve led and the ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... and clothing, announced expansion into Canada to provide its range of unique and ... sales office in Quebec City that will provide bilingual customer service and marketing ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  The Parenteral Drug Association, Inc. (PDA), ... manufacturing sterile drug products, today announced the publication ... – With link to Comparison Spreadsheet. The ... U.S. FDA, the EU, the Pharmaceutical Inspection Convention/Scheme ... --> --> PDA,s Global Sterile ...
(Date:2/8/2016)... LONDON , Feb.8, 2016 Cardiovascular ... Summary GlobalData,s Medical Devices sector report, ... 2015" provides an overview of Cardiovascular Surgery Devices ... --> The report provides comprehensive ... of the products at various stages of development. ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology: